Table 3 Distribution of the VDR Fok I genotypes, alleles, and serum 25-(OH) D in patients with COVID-19 and control group.
From: Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19
Genotype | Patient group | Control group | OR (95% CI) | P | |
---|---|---|---|---|---|
n (180), % | n (200), % | ||||
VDR Fok I | f/f | 83 (46) | 96 (48) | Referent | |
F/f | 60 (33) | 92 (46) | 0.59 (0.38–0.91) | 0.01 | |
F/F | 37 (21) | 12 (6) | 4.05 (1.95–8.55) | <0.001 | |
Alleles | f | 226 (62.8) | 284 (71) | Referent | |
F | 134 (37.2) | 116 (29) | 1.45 (1.06–1.99) | 0.01 | |
Serum 25(OH) D (ng/mL) | 14.7 (6.4–53) | 37.6 (10.3–72.8) | <0.01a |